It's human nature to worry. There's a reason why old adages such as "all good things must come to an end" remain widely used -- we tend to expect something to go wrong.
For income-seeking investors, everything has gone right with AbbVie (NYSE: ABBV) for a long time. The big drugmaker's dividends have steadily increased. But could the good times come to an end in the near future? Just how safe is AbbVie's dividend?
Image source: Getty Images.
Source Fool.com